Acuity Functional Impact and Implementation Outcomes Evaluation

Part of paid clinical trials in Honolulu, Hawaii.

Sponsor
Experiad LLC
Study ID
NCT06561581
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Acuity — BEHAVIORAL
    Enhancement to Motivity product for clinical decision support

Study Details

This study will test feature enhancements to a behavioral therapy data collection software (Motivity) that will add a new clinical decision support module, called Acuity. Acuity is a Quality Improvement (QI) intervention targeted at Behavior Analysts (BAs) and Behavior Technicians (BTs) that aims to improve the delivery of autism behavioral therapy. Subjects will be staff recruited from existing Motivity customers.

Key Dates

Start date
Jul 18, 2024
Status verified
Aug 2024
Primary completion
Aug 31, 2024
Completion
Jul 31, 2025

Study Design

Enrollment
102 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Other: Acuity-Basic
  • Experimental: Acuity-Enhanced

Primary Outcome Measure

Number of participants with improved estimation of Trials to Criterion and Time (days) to Criterion [ Time Frame: through study completion, expected to be 18 months from the start of retroactive observation period ]

Locations (1)

FacilityCityStateZIPSite coordinators
Experiad LLCHonoluluHawaii96816-

Find similar trials in Honolulu, HI

By condition
Autism spectrum disorder
By specialty
Pediatrics
By research site
Experiad LLC· Honolulu, HI

Related Studies